Here's Why Walt Disney (DIS) is a Strong Value Stock — Positive
DIS Zacks Investment Research — January 12, 2026Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Value Investors Buy Lindblad Expeditions (LIND) Stock? — Positive
LIND Zacks Investment Research — January 12, 2026Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Cheesecake Factory (CAKE) is a Strong Value Stock — Positive
CAKE Zacks Investment Research — January 12, 2026The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? — Positive
COLL Zacks Investment Research — January 12, 2026Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term — Positive
TEVA Zacks Investment Research — January 12, 2026Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should Value Investors Buy Cardinal Health (CAH) Stock? — Positive
CAH Zacks Investment Research — January 12, 2026Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why T. Rowe Price (TROW) is a Top Value Stock for the Long-Term — Positive
TROW Zacks Investment Research — January 12, 2026Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Leidos (LDOS) is a Strong Value Stock — Positive
LDOS Zacks Investment Research — January 12, 2026Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term — Positive
UHS Zacks Investment Research — January 12, 2026Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Edison International (EIX) Stock Undervalued Right Now? — Positive
EIX Zacks Investment Research — January 12, 2026Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Rayonier Advanced Materials (RYAM) Stock? — Positive
RYAM Zacks Investment Research — January 12, 2026Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Evertec (EVTC) Stock Undervalued Right Now? — Positive
EVTC Zacks Investment Research — January 12, 2026Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Host Hotels & Resorts (HST) Right Now? — Positive
HST Zacks Investment Research — January 12, 2026Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced — Positive
INSM Zacks Investment Research — January 12, 2026Shares of Insmed rise after it tops FY25 sales forecasts, led by strong Brinsupri uptake, and outlines 2026 guidance and pipeline milestones.
Can Estee Lauder's Fragrance Strength Drive Top-Line Growth? — Positive
EL Zacks Investment Research — January 12, 2026EL sees fragrance emerge as its strongest category, helping drive a return to positive organic sales growth in the fiscal first quarter.
Exelixis Posts Preliminary '25 Results, Issues '26 Outlook — Neutral
EXEL Zacks Investment Research — January 12, 2026EXEL posts approximately $2.32B in 2025 revenues and guides $2.525 -$2.625B for 2026 as Cabometyx grows and a zanzalintinib NDA advances.
SMCI Plunges 45% in 3 Months: Time to Buy, Sell or Hold the Stock? — Neutral
SMCI Zacks Investment Research — January 12, 2026Super Micro Computer shares are down nearly 45% in three months, trading at a discounted P/E as margins compress, cash flow weakens, and AI expansion drives a Hold view.
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) — Positive
ANGO Zacks Investment Research — January 12, 2026AngioDynamics (ANGO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround — Positive
AQST Zacks Investment Research — January 12, 2026Aquestive Therapeutics (AQST) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
SharkNinja, Inc. (SN) Presents at ICR Conference 2026 Transcript — Neutral
SN Seeking Alpha — January 12, 2026SharkNinja, Inc. (SN) Presents at ICR Conference 2026 Transcript